CGON vs DHI · rev $4.0M vs P/E 9.6, rev $34.25B
CG Oncology, Inc. Common stock (CGON) versus DR Horton Inc (DHI) — a side-by-side from cached financials, not a winner call.
CG Oncology, Inc. Common stock (CGON) is a biotechnology company listed on US.
DR Horton Inc (DHI) is a residential construction company listed on US.
Latest reported CGON revenue for 2025-12-31 was $4.0M. Net income was -$161.0M. Revenue was up 254.7% from 2024-12-31 to 2025-12-31. CGON currently screens at market cap $4.74B.
Latest reported DHI revenue for 2025-09-30 was $34.25B. Net income was $3.62B. DHI currently screens at market cap $39.10B and trailing P/E 9.6.
CGON currently screens at market cap $4.74B. DHI currently screens at market cap $39.10B and trailing P/E 9.6.
Not investment advice. Open the CGON and DHI stock pages for the full models.
Not investment advice.